Immunic, Inc.
IMUX
$0.8293
-$0.0229-2.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.44% | 13.90% | -16.70% | -7.02% | 10.91% |
| Total Depreciation and Amortization | 38.71% | 65.38% | 52.17% | 23.53% | 40.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.34% | -78.52% | 45.34% | 13.38% | -19.93% |
| Change in Net Operating Assets | -92.22% | 137.43% | -98.83% | -57.79% | 33.93% |
| Cash from Operations | -44.43% | 9.15% | -63.71% | -20.17% | 14.70% |
| Capital Expenditure | 80.00% | -51.61% | 98.18% | -13.64% | -757.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 80.00% | -51.61% | 98.18% | -13.64% | -104.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -86.26% | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -87.25% | -100.00% | -100.00% |
| Foreign Exchange rate Adjustments | 133.67% | 163.79% | -189.70% | 142.56% | -612.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 332.80% | -142.19% | -79.82% | -17.17% | -13.88% |